|
Financial Instruments
|
3 Months Ended | ||
|---|---|---|---|
|
Mar. 31, 2011
|
|||
| Financial Instruments [Abstract] | |||
| Financial Instruments |
The carrying amount of the Company's financial instruments, including cash and cash equivalents, accounts receivable and accounts payable, notes receivable, accrued expenses and other liabilities approximates fair value due to their relatively short maturity. The Company sold products in various global markets. As a result, the Company was exposed to changes in foreign currency exchange rates. The Company does not hold derivative financial instruments for speculative purposes. Foreign currency transaction gains and (losses) included in other income (expense), were $2 and ($185) for the three months ended June 30, 2011 and 2010, respectively. On June 30, 2011, the Company had no open foreign exchange contracts to sell Euros or any other foreign currencies. On June 30, 2011, the Company had 122,550 warrants outstanding with an exercise price of $30.00 expiring between June 2011 and September 2011. The Company recorded a non-cash gain of $12 and $201 in the quarter ending June 30, 2011 and 2010, respectively, related to these warrants.
|